Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity available at the Rutherford Cancer Centre North West in Liverpool from late 2020.
Dr Chris Tiplady has been a consultant haematologist since 2001 but was awarded his first medical qualification in 1992. His regular work involves treating and supporting people with a wide range of blood cancers: the myeloproliferative neoplasms (polycthaemia rubra vera and essential thrombocythaemia); myelodysplasia, lymphoma; chronic leukaemias and myeloma. He also treats patients with thrombosis, anaemia and haemochromatosis.
His research areas of interest include anaemia, pre-operative optimisation of anaemia and medical education.
Dr Chris Tiplady runs a weekly iron deficiency clinic at the Rutherford Cancer Centre North East. To find out more about booking a consultation, please visit the Rutherford iron clinic - North East page.
British Society of Haematology
Royal College of Pathologists
Northern Regional Haematologists Group
Dr Chris Tiplady does not hold a share or financial interest in the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Chris Tiplady does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Chris Tiplady does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Rutherford Health plc.
Get in Touch
If you'd like to speak to us about any of the treatments we offer please don’t hesitate to get in touch. Call us on 0800 210 0402 or